Grifols SA ADR (NASDAQ: GRFS) has a higher price-to-earnings ratio of 28.68x compared to its average ratio, The 36-month beta value for GRFS is at 0.53. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for GRFS is 258.07M, and currently, shorts hold a 1.19% of that float. The average trading volume for GRFS on June 20, 2025 was 867.18K shares.
GRFS) stock’s latest price update
The stock price of Grifols SA ADR (NASDAQ: GRFS) has jumped by 1.40 compared to previous close of 8.70. Despite this, the company has seen a fall of -1.76% in its stock price over the last five trading days. globenewswire.com reported 2025-06-10 that Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and Commercialization Agreement with Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, for a novel, long-acting biopharmaceutical product.
GRFS’s Market Performance
Grifols SA ADR (GRFS) has seen a -1.76% fall in stock performance for the week, with a 9.72% gain in the past month and a 11.67% surge in the past quarter. The volatility ratio for the week is 2.22%, and the volatility levels for the past 30 days are at 1.53% for GRFS. The simple moving average for the past 20 days is 2.53% for GRFS’s stock, with a 10.43% simple moving average for the past 200 days.
GRFS Trading at 12.78% from the 50-Day Moving Average
After a stumble in the market that brought GRFS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.43% of loss for the given period.
Stock Fundamentals for GRFS
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.39 for the gross margin
The net margin for Grifols SA ADR stands at 0.02. The total capital return value is set at 0.06. Equity return is now at value 3.34, with 0.90 for asset returns.
Based on Grifols SA ADR (GRFS), the company’s capital structure generated 0.63 points at debt to capital in total, while cash flow to debt ratio is standing at 0.09. The debt to equity ratio resting at 1.71. The interest coverage ratio of the stock is 1.67.
Currently, EBITDA for the company is 1.48 billion with net debt to EBITDA at 5.66. When we switch over and look at the enterprise to sales, we see a ratio of 2.11. The receivables turnover for the company is 9.73for trailing twelve months and the total asset turnover is 0.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.60.
Conclusion
In conclusion, Grifols SA ADR (GRFS) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
